ESG

Mindgard's new platform automates attacker-style reconnaissance, aiming to secure AI models before exploits emerge in a rapidly evolving threat landscape.

A new injectable dye entering Phase 3 trials promises to make lung cancer cells glow, helping surgeons remove tumors more completely and prevent recurrence.

Federal banks are funding Quebec's massive Matawinie mine, a strategic move to power North America's EV industry and challenge global supply chains.

A new SHEIN survey reveals Gen Z's multi-outfit festival craze. But as the fast-fashion giant cashes in, its strategy faces mounting ethical scrutiny.

A new Philadelphia facility from Bill Gates' TerraPower aims to increase production of a rare cancer-fighting isotope by 20-fold, breaking a major bottleneck.

Logistics giant Körber and AI leader NVIDIA partner to create hyper-realistic virtual warehouses, accelerating automation and redefining supply chain strategy.

A strategic investment positions Wilkerson Crane Rental to dominate the booming Midwest construction and infrastructure market.

A new partnership uses generative AI to capture real-time insights from community health workers, aiming to build a more responsive healthcare system.

Amid a global scramble for critical minerals, one company's advanced airborne tech promises faster, greener, and more secure resource discovery.

A new study reveals over 211 fake legal cases, largely AI-generated, have infiltrated Canadian courts, threatening justice and hitting the vulnerable hardest.

A Maryland biotech firm has launched FreezOpt, a simple insert that controls ice formation during cell freezing, boosting viability for crucial research.

Galectin Therapeutics adds legendary neurosurgeon Dr. Henry Brem to its board, a strategic move to leverage his drug development expertise for its lead liver drug.

Exiting stealth, PerturbAI releases an 8-million-cell map of gene function in a living brain, aiming to slash the cost and time of creating new drugs.

New solar and battery facilities in Northeast Texas will add 620 MW to the grid, promising economic growth while navigating local community concerns.

Jaguar Uranium re-analyzes old drill cores in Colombia, hunting for rare earths in a bid to create a new, non-Chinese critical minerals hub for the West.

Troilus Mining's new offtake deal with Boliden de-risks its Québec project and highlights Canada's key role in the global critical minerals race.

Qblox's new Massachusetts facility marks a key step for 'Made in America' quantum tech, aiming to enhance U.S. competitiveness and supply chain security.

BioCardia's FDA milestone for its Helix catheter could unlock a new era of targeted heart therapies, but financial hurdles and clinical questions remain.

A new collaboration aims to predict immunotherapy success by mapping protein interactions, offering hope for personalized non-small cell lung cancer treatment.

A new telehealth model challenges the prescription-first approach, combining GLP-1s with 24/7 clinical support. Is this the future of metabolic health?